Skip to main content

 
Presentation Icons
Surgery Day
Surgery Day
Bench to Bedside
Bench to Bedside
SIU@U
SIU@U

  • Friday, Nov 13th
    10:30 - 12:00 CET
    Master Class: Testicular Cancer 2026 - Precision, Pragmatism, and the Long Game
    Co-Chair: Aditya Bagrodia – University of California San Diego
    Co-Chair: Karima Oualla – Hassan II University Hospital
    Testis Cancer
  • Friday, Nov 13th
    10:30 - 10:38 CET
    Guideline-directed Care of Patients with Gcts: What’s New?
    Testis Cancer
  • Friday, Nov 13th
    10:38 - 10:46 CET
    Stage I Seminoma and NSGCT: How Little Is Enough? – Christian Fankhauser (Switzerland) – 8 mins 1. key focus: 1. surveillance vs Adjuvant therapy 2. psychosocial and Fertility outcomes 3. shared Decision-making Frameworks
    Testis Cancer
  • Friday, Nov 13th
    10:46 - 10:54 CET
    Biomarkers that matter: miRNA-371 and ctDNA ?
    Speaker: Clint Cary
    Testis Cancer
  • Friday, Nov 13th
    10:54 - 11:02 CET
    Stage II Seminoma: Modern Algorithms
    Speaker: Aditya Bagrodia – University of California San Diego
    Testis Cancer
  • Friday, Nov 13th
    11:02 - 11:10 CET
    Primary RPLND for Marker-positive NSGCT: Ready for Prime Time?
    Testis Cancer
  • Friday, Nov 13th
    11:10 - 11:18 CET
    Robotic RPLND: Progress and Pitfalls
    Testis Cancer
  • Friday, Nov 13th
    11:18 - 11:26 CET
    Survivorship Is the Endpoint: Long-term Toxicity, Fertility, and Quality of Life
    Speaker: Karima Oualla – Hassan II University Hospital
    Testis Cancer
  • Friday, Nov 13th
    11:26 - 11:34 CET
    Optimal Approach to Post-chemotherapy RPLND
    Speaker: Axel Heidenreich – University Hospital Cologne
    Testis Cancer
  • Friday, Nov 13th
    11:34 - 12:00 CET
    Case-based management of GCTs
    Moderator: Gagan Prakash – Tata Memorial Hospital, Homi Bhabha National Institute
    Panelist: Ofer Yossepowitch – Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel
    Testis Cancer